Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma

World Journal of Surgery

Volumn 22, Issue 6, 1998, Pages 562-568

  Gimm, Oliver ^a   Ukkat, Jörg ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CALCITONIN BLOOD LEVEL; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PROGNOSIS; REOPERATION; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME;

ADULT; AGED; CALCITONIN; CARCINOMA, MEDULLARY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; REOPERATION; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0031926082     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900435     Document Type: Conference Paper

References (31)

1. Saad, M.F., Ordonez, N.G., Rashid, R.K., Giudo, J.J., Hill, C.S., Hickey, R.C., Samaan, N.A.: Medullary carcinoma of the thyroid: a study of clinical features and prognostic factors in 161 patients. Medicine 63:319, 1984
2. Raue, F.: Epidemiology of medullary thyroid carcinoma. Recent Results Cancer Res. 125:47, 1992
3. Pacini, F., Fontanelli, M., Fugazzola, L.: Routine measurement of serum calcitonin in nodular thyroid disease allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 78:826, 1994
4. Rieu, M., Lame, M.C., Richard, A., Lissak, B., Sambort, B., Vuong-Ngoc, P., Berrod, J.L., Fombeur, J.P.: Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement os serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin. Endocrinol. (Oxf.) 42:453, 1995
5. Niccoli, P., Wion-Barbot, N., Caron, P., Henry, J.F., de Micco, C., Saint Andre, J.P., Bigorgne, J.C., Modigliani, E., Conte-Devolx, B.: Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J. Clin. Endocrinol. Metab. 82:338, 1997
6. Vierhapper, H., Raber, W., Bieglmayer, C., Kaserer, K., Weinhaeusl, A., Niederle, B.: Routine measurement of plasma calcitonin in nodular thyroid diseases. J. Clin. Endocrinol. Metab. 82:1589, 1997
7. Raue, R., Kotzerke, J., Reinwein, D., Schröder, S., Röher, H.D., Deckart, H., Höfer, R., Ritter, M., Seif, F., Buhr, H., Beyer, J., Schober, O., Becker, W., Neumann, H., Calvi, J., Winter, J., Vogt, H.: Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German medullary thyroid carcinoma register. Clin. Invest. 71:7, 1993
8. Bergholm, U., Bergström, R., Ekborn, A.: Long term follow-up of patients with medullary carcinoma of the thyroid. Cancer 79:132, 1997
9. Woolner, L.B., Beahrs, O.H., Black, B.M., McConahey, W.M., Keating, F.R.: Thyroid carcinoma: general consideration and follow-up data on 1181 cases. In Thyroid Neoplasia, S. Young, D.R. Inman, editors. London, Academic, 1968, pp. 51-79
10. Schröder, S., Böcker, W., Baisch, H., Bürk, C.G., Arps, H., Meiners, L, Kastendieck, H., Heitz, P.U., Klöppel, G.: Prognostic factors in medullary thyroid carcinomas: survival in relation to age, sex, histology, immunocytochemistry, and DNA content. Cancer 61:806, 1988
11. Tisell, L.E., Hansson, G., Jansson, S., Salander, H.: Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99:60, 1986
12. Van Heerden, J.A., Grant, C.S., Gharib, H., Hay, I.D., Ilstrup, D.M.: Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann. Surg. 212:395, 1990
13. Dralle, H., Damm, I., Scheumann, G.F., Kotzerke, J., Kupsch, E., Geerlings, H., Pichlmayr, R.: Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Jpn. J. Surg. 24:112, 1994
14. Marzano, L.A., Porcelli, A., Biondi, B., Lupoli, G., Delrio, P., Lombardi, G., Zarrilli, L.: Surgical management and follow-up of medullary thyroid carcinoma. J. Surg. Oncol. 59:162, 1995
15. Pelizzo, M.R., Bernante, P., Piotto, A., Toniato, A., Girelli, M.E., Busnardo, B., Rupolo, M., Fassina, A., Pennelli, N.: The extent of surgery for thyroid medullary cancer. Tumori 80:427, 1994
16. Dralle, H., Scheumann, G.F., Kotzerke, J., Brabant, E.G.: Surgical management of MEN 2. Recent Results Cancer Res. 125:167, 1992
17. Lips, C.J., Landsvater, R.M., Hoeppener, J.W., Geerdink, R.A., Blijham, G., Jansen-Schillhorn van Veen, J.M., van Gils, A.P., de Witt, M.J., Zewald, R.A., Berends, M.J., Beemer, F.A., Brouwers-Smalbraak, J., Jansen, R.P., Ploos van Amstel, H.K., van Vroonhoven, T.J., Vroom, T.M.: Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N. Engl. J. Med. 331:828, 1994
18. Hermanek, P., Scheibe, O., Spiessl, B., Wagner, G.: TNM Classification of Malignant Tumors, 4th ed. New York, Springer, 1987, pp. 36-38
19. Dottorini, M.E., Assi, A., Sironi, M., Sangalli, G., Spreafico, G., Colombo, L.: Multivariate analysis of patients with medullary thyroid carcinoma. Cancer 77:1556, 1996
20. Moley, J.F., Wells, S.A., Dilley, W.G., Tisell, L.E.: Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 114:1090, 1993
21. Gimm, O., Dralle, H.: Reoperation in metastasizing medullary thyroid carcinoma. Surgery 122:1124, 1997
22. Dralle, H., Damm, I., Scheumann, G.F., Kotzerke, J., Kupsch, E.: Frequency and significance of cervicomediastinal lymph node metastases in medullary thyroid carcinoma: results of a compartment-oriented microdissection method. Henry Ford Hosp. Med. J. 40:264, 1992
23. Buhr, H.J., Kallinowski, F., Raue, F., Frank-Raue, K., Herfarth, C.: Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma: three-year results. Cancer 72:3685, 1993
24. Girelli, M.E., Dotto, S., Nacamulli, D., Piccolo, M., De Vido, D., Russo, T., Bernante, P., Pelizzo, M.R., Busnardo, B.: Prognostic value of early postoperative calcitonin level in medullary thyroid carcinoma. Tumori 80:113, 1994
25. Scopsi, L., Sampietro, G., Boracchi, P., Del Bo, R., Gullo, M., Placucci, M., Pilotti, S.: Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. Cancer 78:2173, 1996
26. Sandrock, D., Blossey, H.C., Steinroeder, M., Munz, D.L.: Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma. Henry Ford Hosp. Med. J. 37:173, 1989
27. 99mmTc(V)-diamercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma. J. Endocrinol. 144:339, 1995
28. Frank-Raue, K., Bihl, H., Dörr, U., Buhr, H., Ziegler, R., Raue, F.: Somatostatin receptor imaging in persistent medullary thyroid carcinoma. Clin. Endocrinol. (Oxf.) 42:31, 1995
29. Learoyd, D.L., Roach, P.J., Briggs, G.M., Delbridge, L.W., Wilmshurst, E.G., Robinson, B.G.: Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma. J. Nucl. Med. 38:227, 1997
30. Juweid, M., Sharkey, R.M., Behr, T., Swayne, L.C., Rubin, A.D., Herskovic, T., Hanley, D., Markowitz, A., Dunn, R., Siegel, J., Kamal, T., Goldenberg, D.M.: Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. J. Clin. Oncol. 14:1209, 1996
31. Abdelmoumene, N., Schlumberger, M., Gardet, P., Roche, A., Travagli, J.P., Francese, C., Parmentier, C.: Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Br. J. Cancer 69:1141, 1994